Wordt geladen...
Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation
Although it is known that ataxia-telangiectasia mutated (ATM) and interleukin 6 (IL-6) contribute to multiple drug resistance (MDR) in tumor chemotherapy, the exact role of ATM activation in MDR resulting from increased IL-6 expression is still unclear. In the present study, we demonstrate that the...
Bewaard in:
| Gepubliceerd in: | Cancer Sci |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BlackWell Publishing Ltd
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4462389/ https://ncbi.nlm.nih.gov/pubmed/24988892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12478 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|